Heron Therapeutics Inc

NEW
FRA:AXD2 (USA)   Ordinary Shares
€ 0.28 +0.0098 (+3.62%) Sep 4
At Loss
P/B:
11.05
Market Cap:
€ 56.15M ($ 65.25M)
Enterprise V:
€ 147.95M ($ 171.91M)
Volume:
400.00
Avg Vol (2M):
1.50K
Trade In:
Volume:
400.00
At Loss
Avg Vol (2M):
1.50K

Heron Therapeutics Inc (FRA:AXD2) Dividend

Heron Therapeutics Inc (FRA:AXD2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:AXD2 Dividend

Does Heron Therapeutics Inc (FRA:AXD2) pay a dividend?

Heron Therapeutics Inc (FRA:AXD2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Heron Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Heron Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -16.5% over the past 3 years.

What are dividend-paying alternatives to Heron Therapeutics Inc?

For dividend-paying alternatives in Heron Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.